References
Brown AC, Ross J, Jones BD, et al. Risk factors for Acanthamoeba keratitis-a multistate case-control study, 2008-2011. Eye Contact Lens. 2017;44(Suppl 1):S173–8. https://doi.org/10.1097/ICL.0000000000000365.
Radford CF, Bacon AS, Dart JK, Minassian DC. Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ. 1995;310:1567–70.
Garg P, Kalra P, Joseph J. Non-contact lens related Acanthamoeba keratitis. Indian J Ophthalmol. 2017;65:1079–86. https://doi.org/10.4103/ijo.IJO_826_17.
Zhong J, Li X, Deng Y, Chen L, Zhou S, Huang W, et al. Associated factors, diagnosis and management of Acanthamoeba keratitis in a referral center in Southern China. BMC Ophthalmol. 2017;17:175. https://doi.org/10.1186/s12886-017-0571-7.
Dougherty PJ, Binder PS, Mondino BJ, Glasgow BJ. Acanthamoeba sclerokeratitis. Am J Ophthalmol. 1994;117:475–9. https://doi.org/10.1016/S0002-9394(14)70007-8.
Ebrahimi KB, Green WR, Grebe R, Jun AS. Acanthamoeba sclerokeratitis. Graefes Arch Clin Exp Ophthalmol. 2009;247:283–6. https://doi.org/10.1007/s00417-008-0955-8.
Awwad ST, Heilman M, Hogan RN, Parmar DN, Petroll WM, McCulley JP, et al. Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome. Ophthalmology. 2007;1142:313–20. https://doi.org/10.1016/j.ophtha.2006.07.038.
Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology. 1993;1008:1238–43.
Wang Y, Feng X, Jiang L. Current advances in diagnostic methods of Acanthamoeba keratitis. Chin Med J. 2014;127:3165–70.
Lee GA, Gray TB, Dart JK, Pavesio CE, Ficker LA, Larkin DF, et al. Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology. 2002;1096:1178–82.
Chin J, Young AL, Hui M, Jhanji V. Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong. Contact Lens & Anterior Eye. 2015;38:99–103. https://doi.org/10.1016/j.clae.2014.11.146.
Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol. 2000;84:1103–8.
Mascarenhas J, Lalitha P, Prajna NV, Srinivasan M, Das M, D'Silva SS, et al. Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. Am J Ophthalmol. 2014;157:56–62. https://doi.org/10.1016/j.ajo.2013.08.032.
Elabjer BK, Busić M, Sviben M, Elabjer E, Predović J. Painless Acanthamoeba keratitis in a soft contact lens wearer – case report. Coll Antropol. 2009;33:951–4.
Shukla Kent S, Robert MC, Tokarewicz AC, Mather R. Painless acanthamoeba keratitis. Can J Ophthalmol. 2012;47:383–4. https://doi.org/10.1016/j.jcjo.2012.04.015.
Kwok PW, Kam KW, Jhanji V, Young AL. Painless Acanthamoeba keratitis with normal vision. Optom Vis Sci. 2017;94:432–5. https://doi.org/10.1097/OPX.0000000000001023.
Frias B, Merighi A. Capsaicin, nociception and pain. Molecules. 2016;21(6). doi:https://doi.org/10.3390/molecules21060797.
Tenreiro Pinto J, Pereira FC, Loureiro MC, Gama R, Fernandes HL. Efficacy analysis of capsaicin 8% patch in neuropathic peripheral pain treatment. Pharmacology. 2018;101:290–7. https://doi.org/10.1159/000487444.
Kato K, Hirano K, Nagasaka MK, Takashima Y, Kondo M. Histopathological examination of Acanthamoeba sclerokeratitis. Clin Ophthalmol. 2014;8:251–3. https://doi.org/10.2147/OPTH.S54807.
Kuennen RA, Smith RH, Mauger TF, Craig E. Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis. Clin Ophthalmol. 2010;4:1145–9. https://doi.org/10.2147/OPTH.S13831.
Mammo Z, Almeida DR, Cunningham MA, Chin EK, Mahajan VB. Acanthamoeba endophthalmitis after recurrent keratitis and nodular scleritis. Retinal cases and Brief reports. 2017;11:180–2. https://doi.org/10.1097/ICB.0000000000000323.
Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC. Prognostic factor affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115:1998–2003. https://doi.org/10.1016/j.ophtha.2008.04.038.
Bacon AS, Fraser DG, Dart JK. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond). 1993;7:719–25. https://doi.org/10.1038/eye.1993.168.
Shirashi A, Uno T, Oka N, Hara Y, Yamaguchi M, Ohashi Y. In vivo and in vitro laser confocal microscopy to diagnose Acanthamoeba keratitis. Cornea. 2010;29:861–5. https://doi.org/10.1097/ICO.0b013e3181ca36b6.
Kowalski RP, Melan MA, Karenchak LM, Mammen A. Comparison of validated polymerase chain reaction and culture isolation for the routine detection of Acanthamoeba from ocular samples. Eye Contact Lens. 2015;41:341–3. https://doi.org/10.1097/ICL.0000000000000131.
Goh JWY, Harrison R, Hau S, Alexander CL, Tole DM, Avadhanam VS. Comparison of in vivo confocal microscopy, PCR and culture of corneal scrapes in the diagnosis of Acanthamoeba keratitis. Cornea. 2018;37:480–5. https://doi.org/10.1097/ICO.0000000000001497.
Scheid PL, Balczun C. Failure of molecular diagnostics of a keratitis-inducing Acanthamoeba strain. Exp Parasitol. 2017;183:236–9. https://doi.org/10.1016/j.exppara.2017.09.015.
Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997;104:1587–92.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants
All procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Fasciani, R., Brocca, D., Agresta, A. et al. Acanthamoeba Ocular Infection: Anomalous Presentation of a Potentially Vision-Threatening Condition. SN Compr. Clin. Med. 1, 113–117 (2019). https://doi.org/10.1007/s42399-018-0014-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-018-0014-7